BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26960306)

  • 1. Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro.
    Sheng L; Yang X; Ye P; Liu YX; Han CG
    Chin Med Sci J; 2015 Dec; 30(4):245-51. PubMed ID: 26960306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
    Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
    Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro].
    Sheng L; Ye P; Liu YX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1080-4. PubMed ID: 16563274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
    Ye P; Yang W; Wu SM; Sheng L
    Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Pflugers Arch; 2007 Dec; 455(3):443-54. PubMed ID: 17643263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
    Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
    Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin attenuating down-regulation of peroxisome proliferator-activated receptor gamma in preventing cardiac hypertrophy of rats in vitro and in vivo.
    Ye P; Sheng L; Zhang C; Liu Y
    J Pharm Pharm Sci; 2006; 9(3):365-75. PubMed ID: 17207419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
    Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
    Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atorvastatin on cardiomyocyte hypertrophy through suppressing MURC induced by volume overload and cyclic stretch.
    Cheng WP; Lo HM; Wang BW; Chua SK; Shyu KG
    J Cell Mol Med; 2019 Feb; 23(2):1406-1414. PubMed ID: 30511410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
    Yu L; Meng W; Ding J; Cheng M
    Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ; Ding B; Guo ZG; Li YX
    Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II.
    Nozato T; Ito H; Tamamori M; Adachi S; Abe S; Marumo F; Hiroe M
    Jpn Circ J; 2000 Aug; 64(8):595-601. PubMed ID: 10952156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
    Zhang Q; Tan Y; Zhang N; Yao F
    Exp Biol Med (Maywood); 2015 Oct; 240(10):1352-61. PubMed ID: 25488910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and heparan sulfate block angiotensin II-induced hypertrophy in cultured neonatal rat cardiomyocytes. A possible role of intrinsic heparin-like molecules in regulation of cardiomyocyte hypertrophy.
    Akimoto H; Ito H; Tanaka M; Adachi S; Hata M; Lin M; Fujisaki H; Marumo F; Hiroe M
    Circulation; 1996 Feb; 93(4):810-6. PubMed ID: 8641011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
    Zhou DX; Liang QS; He XX; Zhan CY
    Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
    Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
    Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats.
    Jiang H; Zhang C; He W
    Med Sci Monit; 2018 Sep; 24():6322-6330. PubMed ID: 30199522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.